NASDAQ:IKNX

IKONICS (IKNX) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
N/A
50-Day Range
$26.61
$42.31
52-Week Range
N/A
Volume
1,394 shs
Average Volume
136,576 shs
Market Capitalization
$67.16 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
IKNX stock logo

About IKONICS Stock (NASDAQ:IKNX)

IKONICS Corp. engages in the development, manufacture, and trade of photochemical imaging products. It operates through the following business segments: Chromaline, IKONICS Imaging, Digital Texturing (DTX) and Advanced Material Solutions (AMS). The Chromaline Segment sells screen printing film, emulsions, and inkjet receptive film primarily to distributors and some end users. The IKONICS Imaging segment develops and sells photo resistant film, art supplies, glass, metal medium, and abrasive etching equipment. The DTX segment includes patented inkjet technology used for mold texturing and prototyping. The AMS segment supplies sound deadening technology to the aerospace industry. The company was founded in 1952 and is headquartered in Duluth, MN.

IKNX Stock News Headlines

Ikonics reports earnings drop for 2013
Protect Yourself While There’s Still Time …
The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.
Ikonics to sell technology to Japanese auto industry
3 Stocks Pushing The Chemicals Industry Lower
SAATI and IKONICS Sign Definitive Acquisition Agreement
Protect Yourself While There’s Still Time …
The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.
IKONICS Announces Third Quarter 2021 Results
IKONICS Announces Second Quarter 2021 Results
See More Headlines
Receive IKNX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IKONICS and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
4/25/2019
Today
4/26/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Data Processing & Preparation
Sub-Industry
N/A
Current Symbol
NASDAQ:IKNX
Employees
58
Year Founded
N/A

Profitability

Net Income
$-440,000.00
Pretax Margin
-2.48%

Debt

Sales & Book Value

Annual Sales
$13.43 million
Book Value
$5.99 per share

Miscellaneous

Free Float
1,689,000
Market Cap
$67.16 million
Optionable
Not Optionable
Beta
0.90
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

  • Glenn Sandgren
    Chief Executive Officer & Director
  • Kenneth Hegman
    Chief Operating Officer
  • Jon R. Gerlach
    Chief Financial Officer, Secretary & VP-Finance
  • Claude P. Piguet
    Executive Vice President

IKNX Stock Analysis - Frequently Asked Questions

How were IKONICS's earnings last quarter?

IKONICS Co. (NASDAQ:IKNX) announced its quarterly earnings data on Thursday, April, 25th. The specialty chemicals company reported ($0.23) EPS for the quarter. The specialty chemicals company had revenue of $3.53 million for the quarter. IKONICS had a positive trailing twelve-month return on equity of 11.27% and a negative net margin of 2.66%.

What is Bill Ulland's approval rating as IKONICS's CEO?

3 employees have rated IKONICS Chief Executive Officer Bill Ulland on Glassdoor.com. Bill Ulland has an approval rating of 37% among the company's employees. This puts Bill Ulland in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of IKONICS own?
This page (NASDAQ:IKNX) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners